125 related articles for article (PubMed ID: 18046435)
1. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndrome patients.
Caló LA; Davis PA; Pagnin E; Schiavo S; Semplicini A; Pessina AC
J Hum Hypertens; 2008 Mar; 22(3):223-5. PubMed ID: 18046435
[No Abstract] [Full Text] [Related]
2. The search for a link between inflammation and hypertension--contribution from Bartter's/Gitelman's syndromes.
Pagnin E; Davis PA; Semplicini A; Calò LA
Nephrol Dial Transplant; 2006 Aug; 21(8):2340-2. PubMed ID: 16611677
[No Abstract] [Full Text] [Related]
3. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
[TBL] [Abstract][Full Text] [Related]
4. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
Calò LA; Maiolino G
J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
[TBL] [Abstract][Full Text] [Related]
6. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism.
Calò LA; Davis PA; Rossi GP
J Hypertens; 2014 Nov; 32(11):2109-19; discussion 2119. PubMed ID: 25202962
[TBL] [Abstract][Full Text] [Related]
7. The PGC1alpha-PPARdelta-HO-1 system: supporting evidence from studies in Bartter's/Gitelman's syndromes.
Calò LA; Davis PA
Cardiovasc Res; 2010 Jun; 86(3):535. PubMed ID: 20228397
[No Abstract] [Full Text] [Related]
8. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?
Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC
J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975
[TBL] [Abstract][Full Text] [Related]
9. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
[TBL] [Abstract][Full Text] [Related]
10. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension.
Calò LA; Davis PA; Palatini P; Semplicini A; Pessina AC
J Hum Hypertens; 2007 Nov; 21(11):904-6. PubMed ID: 17495949
[No Abstract] [Full Text] [Related]
11. Molecular pathophysiology of Bartter's and Gitelman's syndromes.
Koulouridis E; Koulouridis I
World J Pediatr; 2015 May; 11(2):113-25. PubMed ID: 25754753
[TBL] [Abstract][Full Text] [Related]
12. Does Bartter's syndrome/Gitelman's syndrome provide a clinical model for investigating the association between calcitonin gene-related peptide and angiotensin II-mediated senescence of endothelial progenitor cells?
Tura O; Mills NL; Hadoke PW
J Hypertens; 2010 Oct; 28(10):2170-1; author reply 2171. PubMed ID: 20844373
[No Abstract] [Full Text] [Related]
13. Insulin signaling, glucose metabolism, and the angiotensin II signaling system: studies in Bartter's/Gitelman's syndromes.
Davis PA; Pagnin E; Semplicini A; Avogaro A; Calò LA
Diabetes Care; 2006 Feb; 29(2):469-71. PubMed ID: 16443917
[No Abstract] [Full Text] [Related]
14. Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: support from and opportunities in Bartter's and Gitelman's syndromes patients.
Calò LA; Davis PA
J Hypertens; 2010 Oct; 28(10):2169-70; author reply 2171. PubMed ID: 20844372
[No Abstract] [Full Text] [Related]
15. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.
Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA
High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028
[TBL] [Abstract][Full Text] [Related]
16. Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes.
Calò LA
Kidney Int; 2006 Mar; 69(6):963-6. PubMed ID: 16528244
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
18. ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes.
Calò LA; Rigato M; Bertoldi G
QJM; 2020 Jun; 113(6):440-441. PubMed ID: 31851364
[No Abstract] [Full Text] [Related]
19. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension.
Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA
Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802
[TBL] [Abstract][Full Text] [Related]
20. Bartter's/Gitelman's syndrome: a model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling.
Calò LA; Davis PA; Semplicini A
Clin Nephrol; 2003 May; 59(5):393-4. PubMed ID: 12779105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
